AEON Biopharma

AEON

NASDAQN/A

Income Statement

Total Revenue$0

Gross Profit$0

Operating Income$72.99M

EBITDA$42.1M

EBIT$42.01M

Pre-tax Income$-1.64M

Net Income$42.01M

Net Cash$84.39M

Cash Equivalent$1.39M

Total Debt$12.21M

Net Debt$-72.18M

Book Value$-71.75M

Net Cash Per Share7.31

Book Value Per Share-132.11

Return on Equity (ROE)+2.41%

Return on Assets (ROA)+1336.89%

Return on Invested Capital (ROI)+2.31%

Net Profit Marginundefined

Current Ratio0.11

Quick Ratio0.00

Long-Term Debt / Equitynull